RecruitingNCT06003660

Oral, Chemosensory and Trigeminal Functions in Allo-HSCT

Oral, Chemosensory and Trigeminal Functions in Allogeneic Hematopoietic Stem Cell Transplantation - a Prospective Cohort-study


Sponsor

University of Oslo

Enrollment

70 participants

Start Date

Aug 10, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this prospective, cohort study is to learn about smell, taste and trigeminal dysfunction in patients receiving allogeneic hematopoietic stem cell transplantation (allo-HSCT). The research team hypothesizes that treatment with allo-HSCT will induce: * Distortion of taste and smell and trigeminal functions like cooling, tingling, and burning sensations. * Reduced saliva production leading to oral dryness and dental caries. * Changes in the connectivity of the taste-, smell- and pain-cortical brain regions.


Eligibility

Min Age: 30 YearsMax Age: 70 Years

Inclusion Criteria1

  • patients receiving myeloablative conditioning for a first-time allo-HSCT and diagnosed with either a leukemia or a myelodysplastic syndrome

Exclusion Criteria4

  • disorders affecting the oral cavity including poor tooth-status
  • those using drugs affecting the gustatory/olfactory functions
  • those with brain disorders
  • those who have a chronic disorder affecting the immune system, have cancer or who are pregnant.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

University of Oslo

Oslo, Oslo, Norway

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06003660


Related Trials